Key Dates

  • Board meeting scheduled: Monday, 2nd November, 2026
  • Trading window closure: Continued from previous closure (since 29th September, 2026 letter)
  • Trading window reopening: 48 hours after unpublished price sensitive information is submitted to stock exchanges

Board Meeting Agenda Items

1. Consideration, approval and taking on record of Unaudited Financial Results for the second quarter and half-yearly ended on 30th September, 2026

2. Evaluation of fundraising methods through issuance of equity shares and/or other securities convertible into equity shares, including:

  • Public issue
  • Rights issue
  • Private placement / preferential issue
  • Qualified Institutions Placement(s) (QIP) in one or more tranches
  • Any other method or combination of methods

3. Consideration and approval of specific terms and conditions of fund raise, including (if applicable) determination of issue price in accordance with applicable laws

Conditions and Approvals

Fundraising subject to receipt of necessary approvals including:

  • Approval of members of the Company
  • Regulatory and statutory approvals as may be required

Trading Window Status

Trading window for Company's securities remains closed for Designated Persons and their Immediate Relatives until expiry of 48 hours after unpublished price sensitive information is submitted to Stock Exchanges. This is in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's "Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives."